4//SEC Filing
Siegel Jolie 4
Accession 0001662579-24-000079
CIK 0001662579other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 5:11 PM ET
Size
8.6 KB
Accession
0001662579-24-000079
Insider Transaction Report
Form 4
Siegel Jolie
Chief Legal Officer
Transactions
- Tax Payment
Common Stock
2024-09-16$6.36/sh−661$4,204→ 53,840 total - Exercise/Conversion
Performance Restricted Stock Units
2024-09-16−2,250→ 14,250 totalExp: 2025-02-28→ Common Stock (2,250 underlying) - Exercise/Conversion
Common Stock
2024-09-16+2,250→ 54,501 total
Footnotes (2)
- [F1]Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.
- [F2]Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of PRSUs and does not represent a sale by the Reporting Person.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001768223
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 5:11 PM ET
- Size
- 8.6 KB